Figure 2From: The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cellsInhibition curve of CCI-779 on Bel-7402 growth. Bel-7402 cells were treated with CCI-779 (0.25-28 μM) for 48 h, and the susceptibility to CCI-779 was determined by MTT assay.Back to article page